ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $766,081 | -11.9% | 28,227 | -0.2% | 0.01% | -7.7% |
| Q2 2023 | $869,665 | -14.7% | 28,291 | 0.0% | 0.01% | -27.8% |
| Q1 2023 | $1,019,325 | +17.7% | 28,291 | +29.1% | 0.02% | 0.0% |
| Q4 2022 | $866,041 | -1.7% | 21,914 | 0.0% | 0.02% | -10.0% |
| Q3 2022 | $881,000 | +8.9% | 21,914 | +13.8% | 0.02% | +5.3% |
| Q2 2022 | $809,000 | +7.9% | 19,249 | 0.0% | 0.02% | +18.8% |
| Q1 2022 | $750,000 | -2.2% | 19,249 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $767,000 | +164.5% | 19,249 | +139.6% | 0.02% | +128.6% |
| Q3 2021 | $290,000 | -12.4% | 8,033 | -0.7% | 0.01% | -12.5% |
| Q2 2021 | $331,000 | -6.0% | 8,087 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $352,000 | +10.7% | 8,087 | +27.2% | 0.01% | 0.0% |
| Q4 2020 | $318,000 | – | 6,356 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |